Literature DB >> 18840671

Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.

Lisa A Spencer1, Craig T Szela, Sandra A C Perez, Casey L Kirchhoffer, Josiane S Neves, Amy L Radke, Peter F Weller.   

Abstract

Eosinophils are innate immune leukocytes implicated in the initiation and maintenance of type 2 immune responses, including asthma and allergy. The ability to store and rapidly secrete preformed cytokines distinguishes eosinophils from most lymphocytes, which must synthesize cytokine proteins prior to secretion and may be a factor in the apparent Th2 bias of eosinophils. Multiple studies confirm that human eosinophils from atopic or hypereosinophilic donors can secrete over 30 cytokines with a varying and often opposing immune-polarizing potential. However, it remains unclear whether all of these cytokines are constitutively preformed and available for rapid secretion from eosinophils in the circulation of healthy individuals or are restricted to eosinophils from atopic donors. Likewise, the relative concentrations of cytokines stored within eosinophils have not been studied. Here, we demonstrate that human blood eosinophils are not singularly outfitted with Th2-associated cytokines but rather, constitutively store a cache of cytokines with nominal Th1, Th2, and regulatory capacities, including IL-4, IL-13, IL-6, IL-10, IL-12, IFN-gamma, and TNF-alpha. We demonstrate further rapid and differential release of each cytokine in response to specific stimuli. As agonists, strong Th1 and inflammatory cytokines elicited release of Th2-promoting IL-4 but not Th1-inducing IL-12. Moreover, a large quantity of IFN-gamma was secreted in response to Th1, Th2, and inflammatory stimuli. Delineations of the multifarious nature of preformed eosinophil cytokines and the varied stimulus-dependent profiles of rapid cytokine secretion provide insights into the functions of human eosinophils in mediating inflammation and initiation of specific immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840671      PMCID: PMC2626765          DOI: 10.1189/jlb.0108058

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  39 in total

1.  Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production.

Authors:  David Voehringer; Kanade Shinkai; Richard M Locksley
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

2.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development.

Authors:  C A Wenner; M L Güler; S E Macatonia; A O'Garra; K M Murphy
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

3.  Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation.

Authors:  A M Dvorak; S J Ackerman; T Furitsu; P Estrella; L Letourneau; T Ishizaka
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

4.  Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product.

Authors:  R Moqbel; S Ying; J Barkans; T M Newman; P Kimmitt; M Wakelin; L Taborda-Barata; Q Meng; C J Corrigan; S R Durham; A B Kay
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

5.  Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome.

Authors:  W J Beil; P F Weller; D M Tzizik; S J Galli; A M Dvorak
Journal:  J Histochem Cytochem       Date:  1993-11       Impact factor: 2.479

6.  IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.

Authors:  S Beissert; J Hosoi; S Grabbe; A Asahina; R D Granstein
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

7.  Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes.

Authors:  A Egesten; J Calafat; E F Knol; H Janssen; T M Walz
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

8.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

9.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

10.  Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite.

Authors:  Booki Min; Melanie Prout; Jane Hu-Li; Jinfang Zhu; Dragana Jankovic; Ellen S Morgan; Joseph F Urban; Ann M Dvorak; Fred D Finkelman; Graham LeGros; William E Paul
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

View more
  105 in total

Review 1.  Practical approach to the patient with hypereosinophilia.

Authors:  Florence Roufosse; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

Review 2.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

3.  Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.

Authors:  Kimberly D Dyer; Caroline M Percopo; Zhihui Xie; Zhao Yang; John Dongil Kim; Francis Davoine; Paige Lacy; Kirk M Druey; Redwan Moqbel; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

4.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

Review 5.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 6.  Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils.

Authors:  Rossana C N Melo; Ann M Dvorak; Peter F Weller
Journal:  Microsc Microanal       Date:  2010-09-27       Impact factor: 4.127

7.  Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model.

Authors:  Lorenzo Drago; Lucia Nicola; Enrico Iemoli; Giuseppe Banfi; Elena De Vecchi
Journal:  BMC Res Notes       Date:  2010-02-25

Review 8.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Authors:  Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2018-10-04       Impact factor: 4.962

10.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.